FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016840929> ?p ?o ?g. }

• W3016840929 endingPage "27" @default.
• W3016840929 startingPage "22" @default.
• W3016840929 abstract "Abstract Ancylostoma caninum is the most prevalent intestinal nematode of dogs, and has a zoonotic potential. Multiple-drug resistance (MDR) has been confirmed in a number of A. caninum isolates, including isolate Worthy 4.1F3P, against all anthelmintic drug classes approved for hookworm treatment in dogs in the United States (US). The cyclooctadepsipeptide emodepside is not registered to use in dogs in the US, but in a number of other countries/regions. The objective of this study was to evaluate the efficacy of emodepside + praziquantel, as well as three commercial products that are commonly used in the US for treatment of hookworms, against a suspected (subsequently confirmed) MDR A. caninum isolate Worthy 4.1F3P. 40 dogs infected on study day (SD) 0 with 300 third-stage larvae, were randomly allocated to one of five treatment groups with eight dogs each: pyrantel pamoate (Nemex®-2), fenbendazole (Panacur® C), milbemycin oxime (Interceptor®), emodepside + praziquantel tablets and non-treated control. Fecal egg counts (FEC) were performed on SDs 19, 20, 22, 27, 31 and 34. All treatments were administered as per label requirements on SD 24 to dogs in Groups 1 through 4. Two additional treatments were administered on SDs 25 and 26 to dogs in Group 2 as per label requirements. Dogs were necropsied on SD 34 and the digestive tract was removed/processed for worm recovery and enumeration. The geometric mean (GM) worm counts for the control group was 97.4, and for the pyrantel pamoate, fenbendazole, milbemycin oxime, and emodepside + praziquantel groups were 74.8, 72.0, 88.9, and 0.4, respectively. These yielded efficacies of 23.2%, 26.1%, and 8.8%, and 99.6%, respectively. These data support previous findings of the MDR status of Worthy 4.1F3P as treatments with pyrantel pamoate, fenbendazole and milbemycin oxime lacked efficacy. In sharp contrast, Worthy 4.1F3P was highly susceptible to treatment with emodepside + praziquantel." @default.
• W3016840929 created "2020-04-24" @default.
• W3016840929 creator A5023757615 @default.
• W3016840929 creator A5030532444 @default.
• W3016840929 creator A5039689013 @default.
• W3016840929 creator A5042965460 @default.
• W3016840929 creator A5059035375 @default.
• W3016840929 creator A5061123320 @default.
• W3016840929 creator A5076103103 @default.
• W3016840929 date "2020-08-01" @default.
• W3016840929 modified "2023-09-25" @default.
• W3016840929 title "Efficacy evaluation of anthelmintic products against an infection with the canine hookworm (Ancylostoma caninum) isolate Worthy 4.1F3P in dogs" @default.
• W3016840929 cites W1902889185 @default.
• W3016840929 cites W1934141242 @default.
• W3016840929 cites W1964705727 @default.
• W3016840929 cites W1974678243 @default.
• W3016840929 cites W1979799255 @default.
• W3016840929 cites W1981583975 @default.
• W3016840929 cites W1989706787 @default.
• W3016840929 cites W1995085667 @default.
• W3016840929 cites W1997028209 @default.
• W3016840929 cites W1999826931 @default.
• W3016840929 cites W2000387844 @default.
• W3016840929 cites W2007127994 @default.
• W3016840929 cites W2018163321 @default.
• W3016840929 cites W2027197054 @default.
• W3016840929 cites W2028652414 @default.
• W3016840929 cites W2041327979 @default.
• W3016840929 cites W2050845430 @default.
• W3016840929 cites W2059572045 @default.
• W3016840929 cites W2073866408 @default.
• W3016840929 cites W2074661823 @default.
• W3016840929 cites W2076222842 @default.
• W3016840929 cites W2084586477 @default.
• W3016840929 cites W2085581816 @default.
• W3016840929 cites W2092306308 @default.
• W3016840929 cites W2126321556 @default.
• W3016840929 cites W2132281119 @default.
• W3016840929 cites W2133572946 @default.
• W3016840929 cites W2147663303 @default.
• W3016840929 cites W2152709239 @default.
• W3016840929 cites W2168541751 @default.
• W3016840929 cites W2415650566 @default.
• W3016840929 cites W2911807104 @default.
• W3016840929 cites W2922335981 @default.
• W3016840929 cites W2943934983 @default.
• W3016840929 cites W2944306327 @default.
• W3016840929 cites W2971676613 @default.
• W3016840929 cites W2992289015 @default.
• W3016840929 cites W3006878616 @default.
• W3016840929 cites W4234297355 @default.
• W3016840929 doi "https://doi.org/10.1016/j.ijpddr.2020.04.003" @default.
• W3016840929 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7214830" @default.
• W3016840929 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32403053" @default.
• W3016840929 hasPublicationYear "2020" @default.
• W3016840929 type Work @default.
• W3016840929 sameAs 3016840929 @default.
• W3016840929 citedByCount "20" @default.
• W3016840929 countsByYear W30168409292021 @default.
• W3016840929 countsByYear W30168409292022 @default.
• W3016840929 countsByYear W30168409292023 @default.
• W3016840929 crossrefType "journal-article" @default.
• W3016840929 hasAuthorship W3016840929A5023757615 @default.
• W3016840929 hasAuthorship W3016840929A5030532444 @default.
• W3016840929 hasAuthorship W3016840929A5039689013 @default.
• W3016840929 hasAuthorship W3016840929A5042965460 @default.
• W3016840929 hasAuthorship W3016840929A5059035375 @default.
• W3016840929 hasAuthorship W3016840929A5061123320 @default.
• W3016840929 hasAuthorship W3016840929A5076103103 @default.
• W3016840929 hasBestOaLocation W30168409291 @default.
• W3016840929 hasConcept C159047783 @default.
• W3016840929 hasConcept C165901193 @default.
• W3016840929 hasConcept C203014093 @default.
• W3016840929 hasConcept C2776908094 @default.
• W3016840929 hasConcept C2779103583 @default.
• W3016840929 hasConcept C2780406733 @default.
• W3016840929 hasConcept C2908979412 @default.
• W3016840929 hasConcept C42972112 @default.
• W3016840929 hasConcept C71924100 @default.
• W3016840929 hasConcept C86803240 @default.
• W3016840929 hasConceptScore W3016840929C159047783 @default.
• W3016840929 hasConceptScore W3016840929C165901193 @default.
• W3016840929 hasConceptScore W3016840929C203014093 @default.
• W3016840929 hasConceptScore W3016840929C2776908094 @default.
• W3016840929 hasConceptScore W3016840929C2779103583 @default.
• W3016840929 hasConceptScore W3016840929C2780406733 @default.
• W3016840929 hasConceptScore W3016840929C2908979412 @default.
• W3016840929 hasConceptScore W3016840929C42972112 @default.
• W3016840929 hasConceptScore W3016840929C71924100 @default.
• W3016840929 hasConceptScore W3016840929C86803240 @default.
• W3016840929 hasLocation W30168409291 @default.
• W3016840929 hasLocation W30168409292 @default.
• W3016840929 hasLocation W30168409293 @default.
• W3016840929 hasOpenAccess W3016840929 @default.
• W3016840929 hasPrimaryLocation W30168409291 @default.
• W3016840929 hasRelatedWork W1494489217 @default.
• W3016840929 hasRelatedWork W153625009 @default.
• W3016840929 hasRelatedWork W2092306308 @default.

• next